Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress is increasingly being discussed as a key process in the development and progression of the disease. This is triggered and maintained by multiple factors, including mitochondrial dysfunction, defective dopamine metabolism and chronic neuroinflammation. The resulting imbalance between reactive oxygen species (ROS) and antioxidant defense systems leads to pronounced cellular damage, which ultimately drives the degeneration of dopaminergic cells. Despite intensive research, no curative therapy exists to date.
You May Also Like
- Biophilic Design of Work Environments
Effects on Health, Well-Being, and Productivity
- From symptom to diagnosis
Intrapelvic mass with an ambiguous differential diagnosis
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle
Surgical Challenges and Recurrence Patterns
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Alcohol Consumption While Taking Semaglutide
Withdrawal Symptoms Thanks to GLP-1 RA?
- Why Echocardiography Has Redefined the Clinical Picture